Fate Therapeutics (FATE) Q1 2025 Earnings

Mar 5Confirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.47
-0.42
-0.38
-0.33

Details

Expected EPS
-0.432453
Actual EPS
-0.44
Surprise EPS
-0.01
Surprise Percent
-1.75%

Description

⁨Fate Therapeutics⁩ (⁦FATE⁩) has reported earnings of ⁦-0.44⁩ per share for ⁦Q1 2025⁩.

0 Comments

Share your thoughts